… aerosol production systems. In the current review, we discuss the efficiency of aerosol antibiotic
studies along with aerosol … with cystic fibrosis indicate that the next generation of aerosol …

… infections in cystic fibrosis (CF) patients. Aerosol antibiotic administration can produce local
… The development of aerosol antibiotics has been particularly important for treatment in …

… survival of individuals with cystic fibrosis (CF) is … aerosolized antibiotic formulations have
recently been introduced (such as inhaled aztreonam), and others are in development (inhaled …

… Aerosol antibiotics in … with cystic fibrosis (CF). However, their administration is time-consuming
in patients who must already take a large amount of medication daily Aerosol antibiotics …

… In conclusion, to definitively recommend treatment algorithms for inhaled antibiotics in
non–cystic fibrosis bronchiectasis large-scale, long-term controlled studies are needed. …

… inhaled antibiotics only after patients have suffered repeated exacerbations despite appropriate
use of chronic macrolides, aerosolized … trial of nebulized gentamicin in non-cystic fibrosis …

… This study establishes a method for studying the extra- and intra- puhnonary deposition
of nebulized antibiotics in cystic fibrosis, and demonstrates that in vivo measurement is …

… Inhaled antibiotics have been used for a long … inhaled antibiotics in NCFB patients.
Furthermore, we will address potential future challenges in the widespread use of inhaled antibiotics, …

… The pharmacokinetics of inhaled aminoglycosides and problems associated with aerosolized
antibiotic treatment, including environmental contamination, selection of resistant microbes…

… In conclusion, AZLI is a new inhaled antibiotic for use in adult CF patients with Pseudomonas
aeruginosa infection. Its place in relation to tobramy-cin inhalation solution is not yet …